DBVT News and Press, DBV Technologies S.A. From 10/08/20

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN C...

Westwater Resources (WWR) +53%.Xtant Medical Holdings (XTNT) +29% after regaining compliance with NYSE's continued listing standards.Alteryx (AYX) +25% on raising Q3 revenue guidance.CBAK Energy Technology (CBAT) +22%.Ocean Power Technologies (OPTT) +20%.Oxbridge Re Holdin...

Oxbridge Re Holdings (OXBR) +96%.Perceptron (PRCP) +67% on entering agreement to be acquired by Atlas Copco.Westwater Resources (WWR) +58%.Genfit SA (GNFT) +43% on NASH test deal with LabCorp.Lithium Americas (LAC) +29%.NexTier Oilfield Solutions (NEX) +23%.OpGen (OPGN)&#x...

SPI Energy (SPI) +56% after launching new EV Company.MediciNova (MNOV) +36% on positive intranasal COVID-19 vaccine data.vTv Therapeutics (VTVT) +20% on positive clinical study results supporting the safety and efficacy of TTP399.Athersys (ATHX) +13% af...

Nikola Corporation (NKLA) -26% after Milton resignation sends shockwaves.Eastman Kodak (KODK) -11%.Uranium Energy (UEC) -9%.Eton Pharmaceuticals (ETON) -7%.Deutsche Bank Aktiengesellschaft (DB) -7% on money laundering allegations.ING Groep N.V. (ING) -7%.Plug Power (PLUG) ...

AIMT's stock fell precipitously amid the COVID-19 pandemic, despite receiving FDA approval for its Palforzia treatment (the first FDA approved treatment for peanut allergies). Nestle has commenced a tender offer to purchase shares of AIMT at $34.50 per share and it is trying to take a...

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of August 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 00...

Marinus Pharmaceuticals (NASDAQ: MRNS )   +61%  after ganaxolone successful in pivot study in rare type of epilepsy. More news on: Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Tiziana Life Sciences PLC, Stocks on the move, , Read more ...

DBV Technologies (NASDAQ: DBVT ) appoints  Sebastien Robitaille as CFO effective October 2. More news on: DBV Technologies S.A., Healthcare stocks news Read more ...

Montrouge, France, September 9, 2020 DBV Technologies Announces Leadership Changes DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Ramzi Benamar, Chief Financial Officer, and Kev...